CEO George Paz says Anthem's demands for $3 billion in annual savings are "ludicrous."
The health insurer posted better revenue and earnings results than most had expected.
Can the pharmacy benefit manager make amends with its largest customer? Or is Express Scripts about to lose a huge portion of its revenue? Investors will be searching for answers to these questions in the days ahead.
The health insurance giant reported growth throughout its business and boosted its earnings guidance for the full year.
Healthcare-focused investors had a solid week, but shareholders of this one ETF did the best.
The trends look good for healthcare real estate -- is this the way to play it?
One of the top two pharmacy benefits managers is at risk of losing a major chunk of its business, while the other is on a clear growth path. But there are other fundamentals to consider.
Anthem is looking to get $3 billion it claims Express Scripts owes it.
Insurers allegedly denying eligible patients access to pricey new Hepatitis C drugs will have their day in court.
The health insurance giant hasn't made any gains over the past year. Here's why it could be poised for a fall.